cis-Clopidogrel-MP derivative

• UNSPSC Description:

  cis-Clopidogrel-MP derivative (Clopidogrel-MP-AM) is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite[1]. Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor[2].

• Target Antigen:

  Drug Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/cis-clopidogrel-mp-derivative.html

• Purity:

  97.79

• Solubility:

  DMSO : 2.5 mg/mL (ultrasonic;warming)

• Smiles:

  COC1=CC=CC(C(CSC2CCN([C@H](C(OC)=O)C3=C(Cl)C=CC=C3)C/C2=C/C(O)=O)=O)=C1

• Molecular Weight:

  504.00

• References & Citations:

  [1]Makoto Takahashi, et al. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. harm Biomed Anal. 2008 Dec 1;48(4):1219-24.|[2]Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light, stored under nitrogen)

• Clinical Information:

  No Development Reported

• CAS Number:

  1122047-98-6